Aurora Cannabis Appoints Miguel Martin as CEO NYSE | TSX

Aurora Cannabis Appoints Miguel Martin

EDMONTON, AB, Sept. 8, 2020 /CNW/ - Aurora

Cannabis Inc. (the "Company " or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company

defining the future of cannabinoids worldwide, today announced that Miguel Martin has been appointed Chief Executive Officer, effective

immediately. With deep, diverse experience in consumer packaged goods, highly regulated industries and the U.S. cannabinoid

industry, Miguel is well-positioned to execute the next phase of Aurora's business transformation, with a focus on commercial strategy.

Michael Singer, who has served as Interim CEO since February 2020, has stepped down from his temporary role and will remain Executive

Michael Singer stated, "In his short time

at Aurora, Miguel has demonstrated decisive leadership. Miguel is a highly experienced executive with an exceptional track record

of performance in a number of consumer products categories. After an extensive search which included evaluation of many highly-respected

candidates, Miguel stood apart with both strong commercial and cannabinoid sector expertise, as well as his passion for Aurora's

success. The Aurora Board and I firmly believe that under Miguel's leadership, Aurora's strategic direction going forward will

be characterized by leading market performance, sustainable growth, profitability and value creation for shareholders."

"I am excited to step into the role of

CEO at this inflection point in Aurora's business," said Miguel Martin. "In my early days, I have seen the tremendous

potential of this organization firsthand- a combination of deep industry knowledge, commitment to quality, great brands and a passion

for patients and consumers that is truly differentiated. I am confident that we have the infrastructure and capabilities for long

term success in the global cannabinoid industry. Given my 25 years of executing against regulated product opportunities, including

serving as President of one of the largest electronic cigarette companies, I believe we will be successful both with the current

portfolio and emerging margin accretive formats."

Mr. Martin is a 25-year consumer packaged goods

industry veteran who joined Aurora from Reliva where he served as Chief Executive Officer. He assumed the role of Chief Commercial

Officer of Aurora in July 2020. Prior to Reliva, Mr. Martin was the President of Logic Technology, one of the largest manufacturers

of electronic cigarettes. He also held the position of Senior Vice President and General Manager of Altria Sales & Distribution.

Mr. Martin has deep experience operating in highly regulated industries which will be very additive to Aurora's portfolio of high

quality, rigorously tested and compliant cannabinoid product formats.

Aurora is a global leader in the cannabis industry

serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated

to helping people improve their lives. The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special,

AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products,

Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever

they are launched. For more information, please visit our website at www.auroramj.com.

Aurora's Common Shares trade on the TSX and

NYSE under the symbol "ACB", and is a constituent of the S&P/TSX Composite Index.

Forward Looking Statements

This news release includes statements containing

certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements").

Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect",

"project", "intend", "believe", "anticipate", "estimate", "may", "will",

"potential", "proposed" and other similar words, or statements that certain events or conditions "may"

or "will" occur. These forward-looking statements are only predictions. Various assumptions were used in drawing the

conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking

statements are based on the opinions, estimates and assumptions of management in light of management's experience and perception

of historical trends, current conditions and expected developments at the date the statements are made, such as current and future

market conditions, the current and future regulatory environment and future approvals and permits. Forward-looking statements are

subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances

could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially

from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability

to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora's business transformation

plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required

commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set

out under the heading "Risk Factors" in the Company's annual information form dated September 10, 2019 (the "AIF")

and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com and filed with

and available on the SEC's website at www.edgar.gov. The Company cautions that the list of risks, uncertainties and other factors

described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider

the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place

undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to

update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as

expressly required by applicable securities law.

View original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-appoints-miguel-martin-as-ceo-301125312.html

SOURCE Aurora Cannabis Inc.

View original content to download multimedia:

For further information: For Media: Michelle Lefler, VP, Communications

& PR, media@auroramj.com For Investors: ICR, Inc., Investor Relations, aurora@icrinc.com

CO: Aurora Cannabis Inc.

CNW 07:00e 08-SEP-20